Cantseethewoodsforthetrees
26 Jan 2017
Chart finally looking bullish at 200p level.
Cantseethewoodsforthetrees
24 Jan 2017
Re: Anyone listening You're probably right. Tame buyer/tame seller.Effect on sp's what's important.Time it moved up!
winningstreak
24 Jan 2017
Re: Anyone listening Perhaps a transaction/intermediary commission charged by market makerto both parties (seller and buyer). I often see large transactions of same size at same price, therefore have concluded that there must be commission based deals on behalf of institutional clients, matching seller with buyer.Would welcome other explanation/s by anyone in the know.WS
Cantseethewoodsforthetrees
23 Jan 2017
Re: Anyone listening Hi winningstreak,Could be, but both were at the same price, so buy/sell doesn't make a lot of sense IMHO.Candlestick chart suggests sp could be on the turn.Let's hope so!
winningstreak
23 Jan 2017
Re: Anyone listening One couldl be a Buy, the other could be a sell. Buyer and Seller lined up by market maker, Iwould think - thus share price not affected. IMHO,ws
Cantseethewoodsforthetrees
23 Jan 2017
Re: Anyone listening What's with the 2x100k 'sells' at 9.44 this am?
BigBobby20
23 Jan 2017
Re: Anyone listening I agree with you. I think Trump is after Big Pharma (who want sometimes jaw dropping sums for, e.g., shots of the latest super drug--though the big players and their investors would say rightly so, given developmental costs). But wound closure items seem to me to be the basic, relatively low cost requirements in the health treatment sphere; surgeons and patients can't really opt not to have them.AMS in any case has something of a record of beating the opposition on price, which also helps. And as you point out, with the pound pushed to historic lows thanks to the Brexit debacle, costs may look a bit like a giveaway. Worries over the Trump effect could well be depressing the AMS SP--mistakenly, I believe. What a bargain buy AMS is at the moment. I'm trying to see how I can muster some cash. We'll all kick ourselves when the SP hits 250p....BB20
winningstreak
20 Jan 2017
Re: Anyone listening People need medicines. doctors need plasters, surgeons need sutures, whether Trump likes it or not! What he will like is that AMS's goods are cheaper than the goods from US based companies, even more so nowwith the Pound low against the Dollar.IMHO,ws(p.s. I feel Trump would benefit from a big plaster across his mouth.)
BigBobby20
19 Jan 2017
Below 200 day m.a. Investors committed to AMS and wondering when next to top up should take a look right now at the one year graph. Add in the 200 day e.m.a. and you will see that the SP is on one of its very rare incursions into sub 200 day e.m.a. territory. The last time this occurred was in February of 2016, when the SP spent just a few days below the 200 day line. There have been only three of these these rare occurrences in the last three years, each one lasting at most four or five days before the SP decides to hop back above the line and keep going. I am not qualified to give advice, so rely instead on your own analysis. But if the man sitting next to me in the pub asked what I saw as a no-brainer investment opportunity, this would be top of my list, with the pointer that the phenomenon outlined above is not something that lasts for long. As we know from the AMS trajectory over recent years, history regularly repeats itself. In my view, there is a good chance of a 50p gain this year on a buying price currently of 207p. That would be not far off a 25% return on capital invested. BB20
Cantseethewoodsforthetrees
12 Jan 2017
Anyone listening ...to Trump's anti-pharma rhetoric?SP chart forming a wedge....hmm..
BigBobby20
30 Dec 2016
Re: Into forward gear? In my last post, I referred to December 31st as the date when we would receive more information from the company. My apologies to all, as the intended date of publication of the final results is in fact March 17th 2017 (--December 31st being the last day of the full twelve months of trading).A happy an healthy New Year to all.BB20.
BigBobby20
15 Dec 2016
Re: Into forward gear? Hi Games:Further to my post of 5.12.16, in which I invited you to justify your claim (4.12.16) that AMS is suffering a "growth rate in low single digits", I note that in today's RNS, the trading update talks of a growth in revenue and "profitability in line with current market expectations". CEO Chris Meredith reports "strong organic growth....further supported by ...product innovation allowing us to maintain our leadership position in our chosen market segments". AMS, he concludes," is well positioned to continue on its growth trajectory." You will recall that I predicted something very similar in my response to you. Nothing in this update that I can see to support your view (4.12.16) of "growth...in low single digits". We shall, of course, know more on 31st December. Hopefully, the published results will project a very happy and profitable New Year for all of us and thereby dispel the notion of slump in growth that you outline. BB20
BigBobby20
05 Dec 2016
Re: Into forward gear? Hi Gamesinvestor. Thank you for your response. I was beginning to think other investors had cashed in their chips and left me on here my own.You write, as a cautionary note: "... the share price now implies phenomenal growth."I would put it the other way round: phenomenal growth (or, if phenomenal is an overstatement, then perhaps eye catching, remarkable, hugely impressive) is what we have been getting year after year and a busy pipe line bringing new products to the market, coupled with traction in gaining market share (likely to be eye popping when Resorba sutures attract a following among US surgeons) are driving the SP forward with more to come. I am not sure how you have arrived at a forward growth rate in "low single digits". (You do not say whether you mean revenue, or profits, or SP.) At the interim stage, 2016 group revenue was up 20% compared with H1 2015; adjusted profit before tax was up 16%; net operating cash was up 23%; net cash in hand almost doubled to £41 million; the dividend increased by 20%. I have no hesitation in applying the word "phenomenal" to Liquiband growth in the US, with revenues up 83%. You are right to suggest that companies cannot sustain this kind of performance for ever but the important question is whether our engine has, as you intimatet, run out of steam. The interim results, to my eye, do not conjure up life in the slowcoach lane.My own conviction, based on a careful weighing of the data and the projected roll out of new products, is that we shall arrive at the magical 250p at some point in the New Year and that the 2017 spreadsheets will provide a further cause for celebration. Bids after that (at £3.75? £4.25?) will be OK with me. I'm holding on to my shares, quite emotionally yes, but not at all nervously. BB20
gamesinvestor
04 Dec 2016
Re: Into forward gear? "If you sit well back when you view the chart, it is easy to see in your mind's eye a straight line"Bob I applaud your enthusiasm, but the share price now implies phenomenal growth.With a forward P/W of 28-29 and a growth rate in low single digits, it's easy to get ahead emotionally here. Any slip on the numbers and that rating could be reset and by a lot.I'm holding on with a big chunk, but nervously.Games
BigBobby20
26 Nov 2016
Re: Into forward gear? Strange to see no posts here for a while, given the strong uplift in the SP, especially in the last few days.The chart (see the last four weeks) looks just as if we have had a large molar removed but the resulting, unpleasant gap was not as deep and savage an excavation as the one that occurred in February. That was when the SP completed a drop of 30p and ended up, just for a few days, on the wrong side of the 200 day moving average, touching 155p (and making the share a screaming buy). The SP put on 80p in the next eight months and, despite the set back which seemed to result from profit taking, we are now within a whisker of the all time high. Seven pence to go. The chance that the Santa Rally will carry us on to sail past the high of 235p looks very good and we could see 250p by the New Year. All a game of probabilities rather then certainties, of course.If you sit well back when you view the chart, it is easy to see in your mind's eye a straight line connecting the (each time higher) highs over the last year and a parallel line which connects the (each time higher) lows. Everything is still running on track.... What a share!Bb20
